A detailed history of First Bancorp, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, First Bancorp, Inc holds 2,240 shares of ABBV stock, worth $399,593. This represents 0.31% of its overall portfolio holdings.

Number of Shares
2,240
Previous 2,184 2.56%
Holding current value
$399,593
Previous $374,000 18.18%
% of portfolio
0.31%
Previous 0.28%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $9,175 - $11,162
56 Added 2.56%
2,240 $442,000
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $1,438 - $1,638
-9 Reduced 0.41%
2,184 $397,000
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $5,504 - $6,198
40 Added 1.86%
2,193 $339,000
Q3 2023

Oct 23, 2023

BUY
$133.59 - $154.65 $13,359 - $15,465
100 Added 4.87%
2,153 $320,000
Q2 2023

Jul 19, 2023

SELL
$132.51 - $164.9 $14,576 - $18,139
-110 Reduced 5.09%
2,053 $276,000
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $46,709 - $53,792
323 Added 17.55%
2,163 $344,000
Q4 2022

Feb 01, 2023

SELL
$138.31 - $165.87 $9,128 - $10,947
-66 Reduced 3.46%
1,840 $297,000
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $2,684 - $3,078
-20 Reduced 1.04%
1,906 $256,000
Q2 2022

Jul 14, 2022

SELL
$137.62 - $174.96 $72,250 - $91,854
-525 Reduced 21.42%
1,926 $295,000
Q1 2022

Apr 25, 2022

SELL
$131.98 - $163.75 $14,385 - $17,848
-109 Reduced 4.26%
2,451 $398,000
Q4 2021

Jan 28, 2022

BUY
$107.43 - $135.93 $7,090 - $8,971
66 Added 2.65%
2,560 $346,000
Q3 2021

Oct 19, 2021

SELL
$106.4 - $120.78 $7,235 - $8,213
-68 Reduced 2.65%
2,494 $269,000
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $262,092 - $288,532
2,562 New
2,562 $277,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Bancorp, Inc Portfolio

Follow First Bancorp, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bancorp, Inc , based on Form 13F filings with the SEC.

News

Stay updated on First Bancorp, Inc with notifications on news.